One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain

Thrombosis and Stroke

Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China

J Am Heart Assoc

Ma G, Raynald, Arham A, Jiang Z, Mo R, Zuo Y, Wu Y, Meng S, Lei S, Nguyen TN, Zhong L, EXPAND investigators

doi: 10.1161/JAHA.125.044296

Cardiovascular Risk and Diseases

Semaglutide 2.4 mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE)

Diabetes Obes Metab

Ruseva A, Michalak W, Bassan M, Du EX, Fabricatore A, Hartaigh BÓ, Man T, Ramasubramanian R, Shen P, Song J, Zhao Z, Lopez-Jimenez F

doi: 10.1111/dom.70746

Hypertension

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Drugs Real World Outcomes

Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH

doi: 10.1007/s40801-025-00536-4

Heart, Artery and Coronary Diseases

Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea

Lancet

Lee JM, Lee SH, Gim DH, Lee SY, Choi KH, Ahn JH, Hong YJ, Kim HK, Lee KY, Choo EH, Jeon KH, Kim H, Kang MG, Koh JS, Joh HS, Park TK, Yang JH, Song YB, Choi SH, Gwon HC, Hahn JY, Multicenter FLOW-CMD investigators

doi: 10.1016/S0140-6736(26)00666-5

Atrial Fibrillation

Insomnia and the Risk of Atrial Fibrillation: A Nationwide, Real-World Cohort Study

J Am Heart Assoc

Masuda T, Ejiri K, Kaneko H, Suzuki Y, Miyoshi T, Taya S, Iwasaki K, Nakagawa K, Nishii N, Morita H, Okada A, Fujiu K, Takeda N, Morita H, Yasunaga H, Takeda N, Yuasa S

doi: 10.1161/JAHA.125.045149

Myocardial Infarction

Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study

Cardiovasc Diabetol

Tonnesen PT, Olesen KKW, Gyldenkerne C, Hansen MK, Stødkilde-Jørgensen N, Thrane PG, Andersen MH, Poulsen PL, Thomsen RW, Sattar N, Sørensen HT, Maeng M

doi: 10.1186/s12933-026-03085-4

Atrial FibrillationFurther Publications

Mavacamten in Obstructive Hypertrophic Cardiomyopathy: National Insights on Access and Safety Profile From Real-World Data

J Am Heart Assoc

Fath AR, Aglan A, Naidu SS, Mader MJ, Chilton RJ, Elgendy IY, Maron MS, Rowin EJ

doi: 10.1161/JAHA.125.045994

Atrial Fibrillation

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

J Am Heart Assoc

Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S

doi: 10.1161/JAHA.125.044113

Myocardial Infarction

Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter Study

J Am Coll Cardiol

Glaeser J, Lopez-Ayala P, Kellner C, Boeddinghaus J, Nestelberger T, Koechlin L, Sörensen NA, Haller PM, Bima P, Crisanti L, Spagnuolo CC, Strebel I, Hure G, Sieber S, Rubini Gimenez M, Wildi K, Wussler D, Miro O, Martin-Sanchez FJ, Keller DI, Christ M, Twerenbold R, Mahfoud F, Neumann J, Mueller C, APACE and BACC Investigators

doi: 10.1016/j.jacc.2025.12.056

Related content

Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China

Semaglutide 2.4 mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE)

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea

Insomnia and the Risk of Atrial Fibrillation: A Nationwide, Real-World Cohort Study

Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study

Mavacamten in Obstructive Hypertrophic Cardiomyopathy: National Insights on Access and Safety Profile From Real-World Data

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter Study